BOSTON (PRWEB) February 17, 2015
David J. Dykeman, patent attorney, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property (IP) Group in Boston, served as chair of the life sciences delegation to Israel, “Israel Biomedical and Healthcare Innovation.” In this role, Dykeman led a delegation of biomedical, healthcare, and venture capital (VC) companies for a three-day exploration of innovation in Israel from Feb.2-5, 2015. Participants included senior executives from leading medical technology companies, hospitals, universities, and VC and private equity firms.
Organized by New England-Israel Business Council (NEIBC) and Combined Jewish Philanthropies (CJP), the trip was modeled after Massachusetts Gov. Deval Patrick’s trade mission to Israel in May 2014, and provided senior biomedical and healthcare executives and investors with an insider's look at the “Start-up Nation.” The itinerary included focused meetings with Israeli medical device and healthcare industry leadership, technology entrepreneurs, and policy makers, as well as private meetings with the leadership of several Israeli companies.
On Tuesday, Feb. 3, Greenberg Traurig hosted a dinner reception with leaders in the Israeli life sciences industry. The dinner featured the leadership of Israeli biomedical companies, leading investors, and attorneys from five Greenberg Traurig offices around the world. The attendees learned the latest venture capital trends in Israel.
“With over 750 medical device companies, 300 pharmaceutical/biotech companies, and 170 other life science or healthcare IT companies, Israel is a biomedical and healthcare powerhouse,” said Dykeman. “As one of the most innovative tech hubs in the world, Boston is an ideal strategic partner for Israel. We were delighted to bring this life sciences delegation to Israel to explore opportunities for new business development, investment, and R&D collaboration.”
A registered patent attorney with over 18 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology, and healthcare IT. Dykeman is the founding co-chair of the American Bar Association’s (ABA) Medical Devices Committee, and serves on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
An author of over 45 articles and a speaker at over 40 conferences on medical devices and life sciences intellectual property, Dykeman was honored as a “Life Science Star” by LMG Life Sciences, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
About Greenberg Traurig’s Israel Practice
Greenberg Traurig’s Israel Practice offers clients a global network of professionals with the legal experience, business alliances, technical knowledge, political relations, language capabilities and cultural understanding to deliver innovative legal strategies for Israeli businesses and individuals. The Tel Aviv office serves as a gateway for Israeli businesses and entrepreneurs doing business around the world, as well as companies seeking opportunities within Israel. Greenberg Traurig’s Israel Practice provides a wide range of legal services to clients in Israel who need U.S. and UK counsel, as well as legal services from other international jurisdictions. (Attorneys in the office do not practice Israeli law.) As a result of the firm’s experience advising multinationals with locations in Israel, Europe, the United States, Latin America and Asia, the group’s attorneys are familiar with a variety of legal frameworks and work with clients to bridge the legal and regulatory gaps on cross-border deals. Greenberg Traurig also has a strong track record of matching Israeli companies with strategic partners, potential joint ventures and other business-to-business connections.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1800 attorneys serving clients from 37 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is among the “Power Elite” in the 2014 BTI Client Relationship Scorecard report, which assesses the nature and strength of law firms' client relationships. For additional information, please visit http://www.gtlaw.com.